Depending on the platform, vibe-coding can be expensive. You typically buy credits, and you can quickly burn through them ...

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

Cathie Wood’s ARK Investment Management sharply increased its exposure to AI-driven biotechnology and cryptocurrency during ...

Recursion Pharmaceuticals (RXRX) just delivered encouraging Phase 1b/2 TUPELO data for its FAP drug candidate REC-4881, and that clinical update has quickly reshaped how both Wall Street and ...

Cathie Wood's ARK Invest once again trimmed its stake in Tesla (NASDAQ:TSLA) while increasing exposure to crypto-related stocks, according to a Thursday filing with the SEC. The fund sold 23,110 ...

The newest chapter in the saga of the Na’vi people continues to build their highly detailed world. Here’s a guide to catch you up on the developments.

This live blog is refreshed periodically throughout the day with the latest updates from the market.To find the latest Stock ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

If language is what makes us human, what does it mean now that large language models have gained “metalinguistic” abilities?

With the popularity of AI coding tools rising among some software developers, their adoption has begun to touch every aspect ...

Wondering if Recursion Pharmaceuticals at around $4.83 is a beaten down bargain or a value trap? This breakdown walks through what the current market price is really implying. The stock has bounced ...